Ajanta Pharma USA Inc., based in Bridgewater, NJ, delivers high-quality generic pharmaceuticals with a robust FDA-approved portfolio and a reputation for supply chain reliability in the US market.
Import Shipments
Distribution Centers
Annual Revenue
Founded
Ajanta Pharma USA has recently focused on expanding its FDA-approved product portfolio, strengthening supply chain resilience, and enhancing customer partnerships in response to evolving market demands.
Increased number of ANDA filings and FDA approvals for new generic products
Strategic efforts to expand market presence and reach new customer segments.
Implementation of advanced technologies to improve service delivery and customer experience.
Ajanta Pharma USA Inc. produces and supplies a wide range of generic pharmaceuticals, including immediate-release, extended-release, delayed-release, and powder formulations. The company maintains high safety stock levels to ensure uninterrupted supply, even during global disruptions such as the COVID-19 pandemic. With over 53 ANDA approvals and 47 commercialized products, Ajanta Pharma USA continues to expand its portfolio and market presence. Their operations emphasize regulatory compliance, technological advancement, and customer-focused service.
Bridgewater, New Jersey
1973
Private company
